AMC: Analysts Call For EPS Of -$0.19 In Q2

AMC Entertainment Holdings, Inc. (NYSE: AMC) will report its second quarter financial results on August 4th after market close. Analysts have a consensus $9.09 12-month price target on the company, via a total of 8 analysts, with 3 analysts having hold ratings, 3 analysts have sell ratings and the last 2 analysts have strong sell ratings on the stock.

Seven analysts have revenue estimates for the second quarter. The mean revenue estimate between all seven analysts is $1.18 billion; this number has been revised downwards from $1.25 billion at the start of the year. The highest revenue estimate is $1.28 billion, while the lowest is $1.1 billion.

Onto EBITDA estimates, there are currently seven analysts who have second quarter EBITDA estimates. The mean is currently $78.9 million, with this number having been revised downwards from $148 million at the start of the year. Street high is a $126.6 million EBITDA estimate and the lowest is $15.9 million.

Analysts estimate that quarterly earnings per share will come in at -$0.19, with this number being revised downwards from -$0.11 at the start of the year. The street high estimate is -$0.09 and the lowest estimate is -$0.36 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Red Cloud Fall Mining Showcase 2026 | Day 2

More Gold Without a Bigger Upfront Bill? | Keith Boyle – New Found Gold

The Red Cloud Fall Mining Showcase 2026 | Day 1

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

Columbia Care: Canaccord Reiterates Top Pick Following Green Leaf Medical Acquisition

Last Friday, Columbia Care Inc. (CSE: CCHW) closed their acquisition of Green Leaf Medical which...

Friday, June 18, 2021, 01:30:00 PM

Canaccord: “We Believe The Fundamentals Of Lundin Mining Remain Strong”

This morning, Cannacord Genuity reiterated their C$11 price target and Buy rating on Lundin Mining...

Friday, October 30, 2020, 01:49:00 PM

Columbia Care: Canaccord Drops Price Target To $13

On November 12th, Columbia Care (NEO: CCHW) reported its third quarter financial results. The company...

Sunday, November 21, 2021, 04:52:00 PM

Canaccord: IAMGOLD Has “Few Desirable Options To Plug Funding Gap”

On May 3, IAMGOLD Corporation (TSX: IMG) reported its first quarter results for 2022. The...

Thursday, May 5, 2022, 02:24:00 PM

Xebec Adsorption: Canaccord Gets Bullish On Company, Lifts Price Target

On April 12th, Xebec Adsorption (TSX: XBC) announced that it received a US$113.5 million order...

Saturday, April 16, 2022, 11:17:00 AM